Evidence map›Paper›PMID 27228977›Full record

ArticleBMC cardiovascular disorders2016

Primary skeletal muscle myoblasts from chronic heart failure patients exhibit loss of anti-inflammatory and proliferative activity.

Tahnee Sente, An M Van Berendoncks, An I Jonckheere, Richard J Rodenburg, Patrick Lauwers, Viviane Van Hoof, An Wouters, Filip Lardon, Vicky Y Hoymans, Christiaan J Vrints

Open access · goldAbstract read
In one paragraph

Article in BMC cardiovascular disorders, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Tahnee SenteLaboratory of Cellular and Molecular Cardiology, Antwerp University Hospital, Edegem, Belgium. tahnee.sente@uantwerpen.be.
An M Van BerendoncksDepartment of Cardiology, Antwerp University Hospital, Edegem, Belgium.
An I JonckheereDepartment of Pediatric Neurology, UZ Brussel, Vrije Universiteit Brussel (VUB), Brussels, Belgium.
Richard J RodenburgDepartment of Pediatrics, Nijmegen Center for Mitochondrial Disorders, Translational Metabolic Laboratory, Radboud University Medical Center, Nijmegen, The Netherlands.
Patrick LauwersDepartment of Thoracic and Vascular Surgery, Antwerp University Hospital, Edegem, Belgium.
Viviane Van HoofDepartment of Biochemistry, Antwerp University Hospital, Edegem, Belgium.
An WoutersCenter for Oncological Research (CORE) Antwerp, University of Antwerp, Wilrijk, Belgium.
Filip LardonCenter for Oncological Research (CORE) Antwerp, University of Antwerp, Wilrijk, Belgium.
Vicky Y HoymansLaboratory of Cellular and Molecular Cardiology, Antwerp University Hospital, Edegem, Belgium.
Christiaan J VrintsLaboratory of Cellular and Molecular Cardiology, Antwerp University Hospital, Edegem, Belgium.
Antwerp University Hospital · BEUniversity of Antwerp · BERadboud University Medical Center · NLVrije Universiteit Brussel · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPeripheral skeletal muscle wasting is a common finding with adverse effects in chronic heart failure (HF). Whereas its clinical relevance is beyond doubt, the underlying pathophysiological mechanisms are not yet fully elucidated. We aimed to introduce and characterize the primary culture of skeletal muscle cells from individual HF patients as a supportive model to study this muscle loss. METHODS AND

resultsPrimary myoblast and myotubes cultures were successfully propagated from the m. vastus lateralis of 6 HF patients with reduced ejection fraction (HFrEF; LVEF <45 %) and 6 age and gender-matched healthy donors. HFrEF cultures were not different from healthy donors in terms of morphology, such as myoblast size, shape and actin microfilament. Differentiation and fusion indexes were identical between groups. Myoblast proliferation in logarithmic growth phase, however, was attenuated in the HFrEF group (p = 0.032). In addition, HFrEF myoblasts are characterized by a reduced TNFR2 expression and IL-6 secretion (p = 0.017 and p = 0.016; respectively).

conclusionBiopsy derived primary skeletal muscle myoblasts of HFrEF patients produce similar morphological and myogenic differentiation responses as myoblasts of healthy donors, though demonstrate loss of anti-inflammatory and proliferative activity.

Indexed as

Cell ProliferationCellular SenescenceCase-Control StudiesCells, CulturedChronic DiseaseFemaleHeart FailureHumansInflammationInterleukin-6MaleMiddle AgedMuscular AtrophyMyoblasts, SkeletalMyogenic Regulatory FactorsPAX3 Transcription FactorIL6 protein, humanInterleukin-6Myogenic Regulatory FactorsPAX3 protein, humanPAX3 Transcription FactorPAX7 protein, humanPAX7 Transcription FactorReceptors, Tumor Necrosis Factor, Type IITNFRSF1B protein, humanChronic heart failureMuscle wastingMyoblast culturesxCELLigence

Identifiers

PMID27228977
PMCPMC4880810
OpenAlexW2406869500

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.